SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : biotech insider buys

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: nigel bates12/7/2006 9:27:58 AM
   of 213
 
Small, but smart buys by Reneuron directors the day after IND announcement -

Guildford, UK, 7 December 2006: ReNeuron Group plc (LSE: RENE) today announces
the following purchases of ordinary shares in ReNeuron by directors of the
Company at 19.5p per share.

Name Number of Shares Purchased

Michael Hunt 51500
John Sinden 36000
Mark Docherty 51400(1)
Trevor Jones 25700
Paul Harper 25700

Following these purchases the directors of ReNeuron have the following interests
in issued ordinary shares in ReNeuron:

Name Number of shares Percentage of issued share
capital
Michael Hunt 174,613 0.18%
John Sinden 1,219,925(2) 1.22%
Mark Docherty 146,400(3) 0.15%
Trevor Jones 83,200 0.08%
Paul Harper 83,200 0.08%

The current issued ordinary share capital of the Company is 99,604,700 shares.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext